Is Viking Therapeutics, Inc. (VKTX) A Good Stock To Buy Now? [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on VKTX. Viking Therapeutics, Inc.'s share was trading at $35.53 as of April 20th. Medline (MDLN) Q4 Net Sales Rise 14.8% to $7.8B Following Completion of IPO Photo from Iovance Biotherapeutics website Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. VKTX is positioning itself as a potentially compelling player in the obesity and type-2 diabetes treatment landscape, driven by its lead asset, VK2735, a dual GLP-1/GIP receptor agonist. Read More: 15 AI Stocks That Are Quietly Making Investors Rich Read More: Undervalued AI Stock Poised For Massive Gains: 10000% Upside Potential VK2735 has demonstrated strong efficacy in the Phase 2 VENTURE trials, with subcutaneous dosing delivering up to 14.7% mean weight loss over 13 weeks, outperforming first-generation GLP-1 therapies. While gastrointestinal side effects remain a
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- What is Driving a Strong Bullish Sentiment Towards Viking Therapeutics (VKTX) [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics (VKTX) was upgraded by Truist Financial Corporation to "strong-buy".MarketBeat
- This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street [Yahoo! Finance]Yahoo! Finance
- This Obesity Stock Could More Than Double Over the Next 12 Months, According to Wall Street [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Viking Therapeutics to Report Financial Results for First Quarter 2026 on April 29, 2026PR Newswire
VKTX
Earnings
- 2/11/26 - Miss
VKTX
Sec Filings
- 4/1/26 - Form ARS
- 4/1/26 - Form DEFA14A
- 4/1/26 - Form DEF
- VKTX's page on the SEC website